FindTrial
Sign In

The prevention and treatment effect of dezocine and butorphanol recombination midazolam on intraoperative and postoperative shivering in Cesarean section

The prevention and treatment effect of dezocine and butorphanol recombination midazolam on intraoperative and postoperative shivering in Cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010703
Enrollment
Unknown
Registered
2017-02-25
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraoperative and postoperative shivering

Interventions

group I (prevention group):dezocine (0.1mg/kg) and midazolam(0.03mg/kg)
group II (prevention group):butorphanol(0.01mg/kg) and midazolam(0.03mg/kg)
group III (treatment group):dezocine (0.1mg/kg) and midazolam(0.03mg/kg)
group ? (treatment group):dezocine (0.1mg/kg) and midazolam(0.03mg/kg)

Sponsors

the anesthesia department of Liaocheng Dongchangfu District Maternal and Child Health Care
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: cesarean section, ASA I or II level, Term maternal without cardio-cerebral, lungs and hepatorenal system diseases

Exclusion criteria

Exclusion criteria: Shiver before fetal childbirth and allergy to the test drug

Design outcomes

Primary

MeasureTime frame
Chills score;—

Secondary

MeasureTime frame
Pull reaction classification;Nausea and vomiting;Respiratory depression;Sedation scores;Mean arterial pressure;Heart rate;respiratory rate;—

Countries

China

Contacts

Public ContactShuren Wang

Liaocheng Dongchangfu District Maternal and Child Health Care

1255841421@qq.com+86 18265504885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026